Castration Resistant Prostate Cancer (CRPC) Therapeutics Market Size, Share, Growth & Industry Analysis, By Therapy Type (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiotherapy) By Drug Delivery Method (Oral, Injectable), and Regional Analysis, 2025-2032

1 INTRODUCTION OF THE GLOBAL CRPC THERAPEUTICS MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL CRPC THERAPEUTICS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL CRPC THERAPEUTICS MARKET, BY THERAPY TYPE
6.1 Overview
6.2 Hormonal Therapy
6.3 Chemotherapy
6.4 Immunotherapy
6.5 Radiotherapy

7 GLOBAL CRPC THERAPEUTICS MARKET, BY DRUG DELIVERY METHOD
7.1 Overview
7.2 Oral
7.3 Injectable

8 GLOBAL CRPC THERAPEUTICS MARKET, BY GEOGRAPHY
8.1 Overview

9 NORTH AMERICA
9.1 U.S.
9.2 Canada
9.3 Mexico

10 EUROPE
10.1 Germany
10.2 UK
10.3 France
10.4 Italy
10.5 Spain
10.6 Russia
10.7 Rest of Europe

11 ASIA-PACIFIC
11.1 China
11.2 Japan
11.3 India
11.4 South Korea
11.5 Rest of Asia-Pacific

12 MIDDLE EAST & AFRICA
12.1 GCC
12.2 South Africa
12.3 North Africa
12.4 Rest of Middle East & Africa

13 LATIN AMERICA
13.1 Brazil
13.2 Argentina
13.3 Rest of South America

14 GLOBAL CRPC THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Key Developments
14.3 Key Strategic Developments
14.4 Company Market Ranking
14.5 Regional Footprint
14.6 Industry Footprint

15 COMPANY PROFILES
15.1 Johnson & Johnson
15.1.1 Key Facts
15.1.2 Financial Overview
15.1.3 Product Benchmarking
15.1.4 Recent Developments
15.1.5 Winning Imperatives
15.1.6 Current Focus & Strategies
15.1.7 Threat from competition
15.1.8 SWOT Analysis
15.2 Astellas Pharma Inc.
15.2.1 Key Facts
15.2.2 Financial Overview
15.2.3 Product Benchmarking
15.2.4 Recent Developments
15.2.5 Winning Imperatives
15.2.6 Current Focus & Strategies
15.2.7 Threat from competition
15.2.8 SWOT Analysis
15.3 Bayer AG
15.3.1 Key Facts
15.3.2 Financial Overview
15.3.3 Product Benchmarking
15.3.4 Recent Developments
15.3.5 Winning Imperatives
15.3.6 Current Focus & Strategies
15.3.7 Threat from competition
15.3.8 SWOT Analysis
15.4 Pfizer, Inc.
15.4.1 Key Facts
15.4.2 Financial Overview
15.4.3 Product Benchmarking
15.4.4 Recent Developments
15.4.5 Winning Imperatives
15.4.6 Current Focus & Strategies
15.4.7 Threat from competition
15.4.8 SWOT Analysis
15.5 AstraZeneca
15.5.1 Key Facts
15.5.2 Financial Overview
15.5.3 Product Benchmarking
15.5.4 Recent Developments
15.5.5 Winning Imperatives
15.5.6 Current Focus & Strategies
15.5.7 Threat from competition
15.5.8 SWOT Analysis
15.6 Novartis
15.6.1 Key Facts
15.6.2 Financial Overview
15.6.3 Product Benchmarking
15.6.4 Recent Developments
15.7 Merck & Co.
15.7.1 Key Facts
15.7.2 Financial Overview
15.7.3 Product Benchmarking
15.7.4 Recent Developments
15.8 Sanofi S.A.
15.8.1 Key Facts
15.8.2 Financial Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments
15.9 Dendreon Corporation
15.9.1 Key Facts
15.9.2 Financial Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments
15.10 AbbVie, Inc.
15.10.1 Key Facts
15.10.2 Financial Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 2 Global CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 3 Global CRPC THERAPEUTICS Market Revenue, By Geography, 2022 – 2032 (USD Billion)
TABLE 4 North America CRPC THERAPEUTICS Market Revenue, By Country, 2022 – 2032 (USD Billion)
TABLE 5 North America CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 6 North America CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 7 US CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 8 US CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 9 Canada CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 10 Canada CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 11 Mexico CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 12 Mexico CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 13 Europe CRPC THERAPEUTICS Market Revenue, By Country, 2022 – 2032 (USD Billion)
TABLE 14 Europe CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 15 Europe CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 16 Germany CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 17 Germany CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 18 France CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 19 France CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 20 UK CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 21 UK CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 22 Spain CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 23 Spain CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 24 Italy CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 25 Italy CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 26 Russia CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 27 Russia CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 28 Rest of Europe CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 29 Rest of Europe CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 30 Asia-Pacific CRPC THERAPEUTICS Market Revenue, By Country, 2022 – 2032 (USD Billion)
TABLE 31 Asia-Pacific CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 32 Asia-Pacific CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 33 China CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 34 China CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 35 Japan CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 36 Japan CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 37 India CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 38 India CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 39 South Korea CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 40 South Korea CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 41 Rest of Asia-Pacific CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 42 Rest of Asia-Pacific CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 43 Middle East and Africa CRPC THERAPEUTICS Market Revenue, By Country, 2022 – 2032 (USD Billion)
TABLE 44 Middle East and Africa CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 45 Middle East and Africa CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 46 GCC CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 47 GCC CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 48 North Africa CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 49 North Africa CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 50 South Africa CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 51 South Africa CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 52 Rest of Middle East & Africa CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 53 Rest of Middle East & Africa CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 54 Latin America CRPC THERAPEUTICS Market Revenue, By Country, 2022 – 2032 (USD Billion)
TABLE 55 Latin America CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 56 Latin America CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 57 Brazil CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 58 Brazil CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 59 Argentina CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 60 Argentina CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 61 Rest of Latin America CRPC THERAPEUTICS Market Revenue, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
TABLE 62 Rest of Latin America CRPC THERAPEUTICS Market Revenue, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
TABLE 63 Company Market Ranking
TABLE 64 Regional Footprint
TABLE 65 Product Benchmarking
TABLE 66 Recent Developments
TABLE 67 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global CRPC THERAPEUTICS Market 2022 – 2032 (USD Billion)
FIG. 4 Global CRPC THERAPEUTICS Market Geographical Analysis (CAGR %)
FIG. 5 Global CRPC THERAPEUTICS Absolute Market Opportunity (USD Billion)
FIG. 6 Global CRPC THERAPEUTICS Market Attractiveness (USD Billion)
FIG. 7 Global CRPC THERAPEUTICS Market, BY THERAPY TYPE, 2022 – 2032 (USD Billion)
FIG. 8 Global CRPC THERAPEUTICS Market, BY DRUG DELIVERY METHOD, 2022 – 2032 (USD Billion)
FIG. 9 Research Methodology
FIG. 10 Research Process
FIG. 11 Bottom-Up Approach
FIG. 12 Top-Bottom Approach
FIG. 13 Market Dynamics Overview
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Value Chain Analysis
FIG. 16 Macroeconomic Analysis
FIG. 17 Global CRPC THERAPEUTICS Market Revenue Share, BY THERAPY TYPE, 2021 and 2031 (%)
FIG. 18 Global CRPC THERAPEUTICS Market Revenue Share, BY DRUG DELIVERY METHOD, 2021 and 2031 (%)
FIG. 19 Global CRPC THERAPEUTICS Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 20 Market Size and Projections, 2022 - 2032 (USD Billion)
FIG. 21 North America CRPC THERAPEUTICS Market Overview Share, By Countries, 2022 – 2032 (%)
FIG. 22 Market Size and Projections, 2022 - 2032 (USD Billion)
FIG. 23 Europe CRPC THERAPEUTICS Market Overview Share, By Countries, 2022 – 2032 (%)
FIG. 24 Market Size and Projections, 2022 - 2032 (USD Billion)
FIG. 25 Asia-Pacific CRPC THERAPEUTICS Market Overview Share, By Countries, 2022 – 2032 (%)
FIG. 26 Market Size and Projections, 2022 - 2032 (USD Billion)
FIG. 27 Middle East & Africa CRPC THERAPEUTICS Market Overview Share, By Countries, 2022 – 2032 (%)
FIG. 28 Market Size and Projections, 2022 - 2032 (USD Billion)
FIG. 29 Latin America CRPC THERAPEUTICS Market Overview Share, By Countries, 2022 – 2032 (%)
FIG. 30 Key Strategic Development
FIG. 31 Key Facts
FIG. 32 Financial Overview
FIG. 33 SWOT Analysis